Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Nong Yang
CONTACT
Lead
Hunan Cancer Hospital
With
Primary outcome: 1. Analysis of baseline levels of CTC and CTC PD-L1 and prognosis efficacy of patients: Objective remission rate (ORR), progression free survival (PFS), overall survival (OS); 2. Dynamic monitoring of CTC and CTC PD-L1 at baseline before treatment, after two cycles of treatment, and as the disease progresses. 3. Consistency analysis of PD-L1 and CTC PD-L1 expression in tissue specimens. Secondary outcome: Duration of response(DOR), Disease control rate(DCR), Safety of the combination therapy.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted